[Observation and multifactor analysis of refractory medium-severe heart failure by micro-inflammation modification in uremic patients].

Objective: To investigate the therapeutic strategies and prognostic factors of refractory medium-severe heart failure in uremic patients.

Methods: A single center, self control clinical research was conducted, and the data consisted of 30 uremic patients with refractory medium-severe heart failure undergoing maintenance hemodialysis (MHD), who received routine combined modality therapy and Xuebijing injection (to modify micro-inflammation). The systolic function of the left ventricle was compared before and after therapy.